Growth Metrics

Evolent Health (EVH) Equity Ratio (2016 - 2026)

Evolent Health has reported Equity Ratio over the past 12 years, most recently at 0.22 for Q4 2025.

  • For Q4 2025, Equity Ratio fell 44.45% year-over-year to 0.22; the TTM value through Dec 2025 reached 0.22, down 44.45%, while the annual FY2025 figure was 0.22, 44.45% down from the prior year.
  • Equity Ratio for Q4 2025 was 0.22 at Evolent Health, down from 0.34 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.49 in Q4 2021 and troughed at 0.22 in Q4 2025.
  • A 5-year average of 0.42 and a median of 0.42 in 2024 define the central range for Equity Ratio.
  • Biggest five-year swings in Equity Ratio: plummeted 45.47% in 2021 and later increased 3.09% in 2024.
  • Year by year, Equity Ratio stood at 0.49 in 2021, then dropped by 3.22% to 0.47 in 2022, then fell by 15.77% to 0.4 in 2023, then decreased by 1.21% to 0.39 in 2024, then crashed by 44.45% to 0.22 in 2025.
  • Business Quant data shows Equity Ratio for EVH at 0.22 in Q4 2025, 0.34 in Q3 2025, and 0.36 in Q2 2025.